GSEA similarly identified an enrichment in immunoregulatory pathway proteins in Neuro-PASC patients and conversely, elevated antiviral and Th1-type inflammatory pathway proteins such as IL-12 and IL-3 in convalescent controls (Figure 6A). This evidence concerns the gene IL3 and long COVID-19.